cetuximab - Robuta Search

https://pubmed.ncbi.nlm.nih.gov/27073643/ Concomitant cetuximab and radiation therapy: A possible promising strategy for locally advanced... Non-melanoma skin cancers (NMSCs) include a heterogeneous group of malignancies arising from the epidermis, comprising squamous cell carcinoma (SCC), basal... radiation therapy https://researchcollaborations.elsevier.com/en/publications/sub-network-enrichment-and-cluster-analysis-reveal-possible-pathw/ Sub-Network enrichment and cluster analysis reveal possible pathways for cetuximab sensitivity -... network enrichment cluster analysis https://neurosurgery.weill.cornell.edu/research/publications/intraarterial-delivery-bevacizumab-and-cetuximab-utilizing-blood-brain-barrier Intraarterial delivery of bevacizumab and cetuximab utilizing blood-brain barrier disruption in... blood brain barrier https://pubmed.ncbi.nlm.nih.gov/41462474/ Correction: Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with... Correction: Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy https://pubmed.ncbi.nlm.nih.gov/18473010/ Review of cetuximab in the treatment of squamous cell carcinoma of the head and neck Cetuximab is a monoclonal antibody able to inhibit and to degrade the transmembrane receptor Her-1, also known as epidermal growth factor receptor (EGFR). The... squamous cell carcinoma the treatment https://health.economictimes.indiatimes.com/tag/cetuximab Cetuximab - Latest cetuximab , Information & Updates - Health -ET HealthWorld ETHealthworld.com brings latest cetuximab news, views and updates from all top sources for the Indian Health industry. latest information cetuximab updates health https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2024-01652&r=1 PD-L1 t-haNK with N-803 and Cetuximab for the Treatment of Patients with Recurrent and Metastatic... PD-L1 t-haNK with N-803 and Cetuximab for the Treatment of Patients with Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma https://pubmed.ncbi.nlm.nih.gov/22446022/ Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic... Analysis of pooled data from the CRYSTAL and OPUS studies confirms the consistency of the benefit obtained across all efficacy end-points from adding cetuximab... https://adisinsight.springer.com/trials/700248479?error=cookies_not_supported&code=b20de4a2-f764-4af2-88db-fa531c62e28d Phase I Study of Temsirolimus and Cetuximab in Adults Patients With Advanced or Metastatic Solid... This study is investigating cetuximab and temsirolimus in patients with solid tumors. Dose-escalation phase followed 3 + 3 study design. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-encorafenib-cetuximab-and-mfolfox6-metastatic-colorectal-cancer-braf FDA grants accelerated approval to encorafenib with cetuximab and mFOLFOX6 for metastatic... The Food and Drug Administration granted accelerated approval to encorafenib (Braftovi, Array BioPharma Inc., a subsidiary of Pfizer Inc.) with cetuximab and... accelerated approval https://pubmed.ncbi.nlm.nih.gov/20616911/ Recent results of cetuximab use in the treatment of squamous cell carcinoma of the head and neck Cetuximab is a chimeric monoclonal antibody that targets the epidermal growth factor receptor. The role of cetuximab is paramount in several subsets of head... https://epub.ub.uni-muenchen.de/63675/ A genetic variant in Rassf1a predicts outcome in mCRC patients treated with cetuximab plus... https://adisinsight.springer.com/drugsafety/803163497?error=cookies_not_supported&code=48795324-5e29-4fca-b53d-b5d21b6b025c Cetuximab/cisplatin/fluorouracil - AdisInsight A 53-year-old woman developed mucositis following the administration of cetuximab, cisplatin and fluorouracil [dosages not stated; not all routes stated]. Her cetuximab cisplatin fluorouracil adisinsight https://pubmed.ncbi.nlm.nih.gov/21635994/ Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal... First-line treatment with cetuximab plus FOLFIRI offers a cost-effective treatment option versus bevacizumab plus FOLFOX for the metastatic colorectal cancer... https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-study-looking-giving-biological-therapy-as-well-as-combined-chemotherapy-and-radiotherapy-before-surgery-cancer-back-passage-xerxes A study looking cetuximab, chemoradiotherapy and surgery for rectal cancer (XERXES) This study looked at having cetuximab as well as chemoradiotherapy before surgery for cancer of the back passage (rectal cancer). a study rectal cancer looking cetuximab chemoradiotherapy https://researchconnect.buffalo.edu/en/publications/a-phase-ii-study-of-high-dose-cetuximab-plus-irinotecan-in-colore/ A Phase II Study of High-Dose Cetuximab plus Irinotecan in Colorectal Cancer Patients with KRAS... https://scholars.duke.edu/publication/1405574 Scholars@Duke publication: ICECREAM: randomised phase II study of cetuximab alone or in combination... https://www.cancer.gov/about-cancer/treatment/drugs/cetuximab Cetuximab - NCI This page contains brief information about cetuximab (Erbitux) and a collection of links to more information about the use of this drug, research results, and... cetuximab nci https://scholars.duke.edu/grant/132844 Scholars@Duke grant: Phase II trial of Cetuximab & Carboplatin in Basal-like Breast Cancer https://pure.psu.edu/en/publications/dual-inhibition-of-the-epidermal-growth-factor-receptor-with-cetu/ Dual inhibition of the epidermal growth factor receptor with cetuximab, an IgG1 monoclonal... epidermal growth factor https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.795381/full Frontiers | Triple-Regimen of Vemurafenib, Irinotecan, and Cetuximab for the Treatment of... Mutation of the BRAF proto-oncogene is found in approximately 10% of colorectal cancers (CRC), with much of the mutation conferred by a V600E mutation. Unlik... for the frontiers triple regimen vemurafenib https://adisinsight.springer.com/drugsafety/803791594?error=cookies_not_supported&code=11dd6b50-956c-425d-8baa-725f62b0e32f Cetuximab - AdisInsight In a retrospective observational study involving 14 patients treated from January 2018 to September 2022, a female patient [age not stated] was described, who cetuximab adisinsight https://adisinsight.springer.com/trials/700364713?error=cookies_not_supported&code=ce9be482-d91b-42a5-bd0a-87845f52c775 A Phase 2, Randomized, Multicenter, Open-label, Study of FID-007 in Combination With Cetuximab in... The goal of this FID-007 Clinical Trial is to compare the efficacy of different dosing regimens of FID-007 in combination with Cetuximab in patients with https://pubs.rsc.org/en/content/articlelanding/2024/an/d3an01877f Label-free mapping of cetuximab in multi-layered tumor oral mucosa models by atomic... Sensitive mapping of drugs and drug delivery systems is pivotal for the understanding and improvement of treatment options. Since labeling alters the... https://www.nice.org.uk/guidance/ta439 Overview | Cetuximab and panitumumab for previously untreated metastatic colorectal cancer |... Evidence-based recommendations on cetuximab (Erbitux) and panitumumab (Vectibix) for previously untreated RAS wild-type metastatic colorectal cancer in adults overview cetuximab panitumumab previously untreated https://medlineplus.gov/druginfo/meds/a607041.html Cetuximab Injection: MedlinePlus Drug Information Cetuximab Injection: learn about side effects, dosage, special precautions, and more on MedlinePlus cetuximab injection medlineplus drug information https://researchportalplus.anu.edu.au/en/publications/erosive-pustular-dermatosis-of-the-scalp-following-cetuximab/ Erosive pustular dermatosis of the scalp following cetuximab - The Australian National University of the dermatosis https://data.mendeley.com/datasets/b383grhp4y/3 The gold nanoparticles coated with cetuximab induce apoptosis in cancer cells even under... This document presents the raw data regarding the effects of acidic and alkaline solutions, temperature and buffers on the colloidal stability of uncovered... https://pubmed.ncbi.nlm.nih.gov/26090075/ Locoregional therapy and systemic cetuximab to treat colorectal liver metastases DEBIRITUX seems to be efficacious after first line chemotherapy for the treatment of unresectable CRC-LM. therapy systemic cetuximab treat colorectal https://publikationen.uni-tuebingen.de/xmlui/handle/10900/59411 AXL Mediates Resistance to Cetuximab Therapy axl resistance cetuximab therapy https://research.monash.edu/en/projects/a-randomized-phase-3-study-of-mrtx849-in-combination-with-cetuxim/ A Randomized Phase 3 Study of MRTX849 in Combination with Cetuximab versus Chemotherapy in Patients... https://adisinsight.springer.com/drugsafety/803926512?error=cookies_not_supported&code=77cbfd94-7a7d-42f1-9d3a-850514b0412f Cetuximab/Encorafenib/Folfox regimen - AdisInsight A 26-year-old man with BRAF V600E-mutant, microsatellite-stable rectal adenocarcinoma, liver metastases and peritoneal carcinomatosis developed severe adverse cetuximab encorafenib folfox regimen adisinsight https://research.monash.edu/en/publications/dual-targeting-of-the-epidermal-growth-factor-receptor-using-the-/ Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and... epidermal growth factor dual targeting of the https://adisinsight.springer.com/drugsafety/803927573?error=cookies_not_supported&code=5e56b1b2-27af-48c2-a180-207802e90e05 Cetuximab - AdisInsight A multicentre retrospective report described patients [age and sex not stated] with RAS/RAF wild-type metastatic colorectal cancer who received first-line cetuximab adisinsight https://pure.psu.edu/en/publications/safety-and-tumor-specificity-of-cetuximab-irdye800-for-surgical-n/ Safety and tumor specificity of cetuximab-IRDye800 for surgical navigation in head and neck cancer... https://hsrc.himmelfarb.gwu.edu/gwhpubs/972/ "Phase II Trial of CDX-3379 and Cetuximab in Recurrent/Metastatic, HPV-" by Julie E. Bauman,... In phase I development, CDX-3379, an anti-ErbB3 monoclonal antibody, showed promising molecular and antitumor activity in head and neck squamous cell carcinoma... https://pure.psu.edu/en/publications/in-vivo-fluorescence-immunohistochemistry-localization-of-fluores/ In Vivo Fluorescence Immunohistochemistry: Localization of Fluorescently Labeled Cetuximab in... in vivo fluorescence immunohistochemistry localization labeled https://www.cancerresearchuk.org/about-cancer/treatment/drugs/cetuximab Cetuximab (Erbitux) | Cancer drugs | Cancer Research UK Cetuximab is a type of targeted cancer drug. It is a treatment for advanced bowel cancer and neck cancers. Find out about how you have it, possible side... cancer drugs cetuximab erbitux research uk https://pubmed.ncbi.nlm.nih.gov/25375154/ Statin use is not associated with improved progression free survival in cetuximab treated KRAS... Statins may inhibit the expression of the mutant KRAS phenotype by preventing the prenylation and thus the activation of the KRAS protein. This study was aimed... https://adisinsight.springer.com/drugsafety/801090127?error=cookies_not_supported&code=69aa6911-aa8e-48cf-b8a1-30e2f53d9b46 Cetuximab - AdisInsight An 85-year-old woman, who had a history of resected squamous cell cancer of the lip, received cetuximab [dosage and duration of treatment not stated] as part of cetuximab adisinsight https://adisinsight.springer.com/drugsafety/801043805?error=cookies_not_supported&code=d2d9508e-91f1-408d-acb0-2790091e2d2f Cetuximab - AdisInsight A 71-year-old man developed transient acantholytic dermatosis (Grover's disease) during treatment with cetuximab for metastatic colon cancer.As part of a cetuximab adisinsight